← Back to Search

CRP + S&A for Substance Use Disorders (CRP and S&A Trial)

N/A
Recruiting
Led By Elizabeth J. Santa Ana, PhD MA BA
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Functioning at an intellectual level sufficient to allow accurate completion of all assessments
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 month
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing three different treatments to help improve outcomes for people with substance abuse problems. Veterans at the Charleston VA Psychiatric inpatient unit who are admitted may be invited to participate.

Who is the study for?
This trial is for veterans with substance use problems who are inpatients at the Charleston VA Psychiatric unit. Participants must understand English, be able to consent, complete assessments, and commit to therapy sessions and follow-ups. They should have used substances within the last 30 days and meet criteria for a current substance use disorder.
What is being tested?
The study compares three treatments: Combined Recovery Program (CRP) with six group sessions on the unit; Stable & Able (S&A), a telehealth program before discharge providing support up to 3 months; and Treatment-as-usual (TAU), which includes various recovery-related mental health topics.
What are the potential side effects?
Since this trial involves psychological therapies rather than medications, traditional side effects like those seen with drugs are not expected. However, participants may experience emotional discomfort or distress during therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can understand and complete all required tests and questionnaires.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Alcohol Drink Days at 1 Month
Alcohol Drink Days at 3 Month
Alcohol Drink Days at Baseline
+24 more
Secondary study objectives
Addiction Severity Index-Lite (ASI-Lite) at 1 month for Alcohol Use
Addiction Severity Index-Lite (ASI-Lite) at 1 month for Psychiatric Status
Alcohol Use Disorder
+22 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Combined Recovery Program (CRP)+Treatment-as-usual (TAU)Experimental Treatment1 Intervention
Combined Recovery Program (CRP) is a six-session motivational enhancement and daily living skills therapy workshop provided while on the inpatient unit. Attendance of CRP will be in addition to Treatment as Usual (TAU), that is, standard inpatient programming.
Group II: CRP+ Stable & Able (S&A)+TAUActive Control2 Interventions
Combined Recovery Program (CRP) a six-session motivational enhancement and daily living skills therapy workshop provided while on the inpatient unit, plus a home telehealth program (Stable \& Able) which begins on day 1 of hospital discharge. Attendance of CRP and S\&A will be in addition to TAU, that is, standard inpatient programming.
Group III: Treatment-as-usual only (TAU):Active Control1 Intervention
TAU will only receive the usual care on the inpatient unit including medical and medication management.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,530 Total Patients Enrolled
3 Trials studying Dual Diagnosis
652 Patients Enrolled for Dual Diagnosis
Elizabeth J. Santa Ana, PhD MA BAPrincipal InvestigatorRalph H. Johnson VA Medical Center, Charleston, SC
2 Previous Clinical Trials
365 Total Patients Enrolled
2 Trials studying Dual Diagnosis
365 Patients Enrolled for Dual Diagnosis

Media Library

Combined Recovery Program Clinical Trial Eligibility Overview. Trial Name: NCT05054738 — N/A
Dual Diagnosis Research Study Groups: Combined Recovery Program (CRP)+Treatment-as-usual (TAU), CRP+ Stable & Able (S&A)+TAU, Treatment-as-usual only (TAU):
Dual Diagnosis Clinical Trial 2023: Combined Recovery Program Highlights & Side Effects. Trial Name: NCT05054738 — N/A
Combined Recovery Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05054738 — N/A
~31 spots leftby May 2025